Highly infectious prions generated by a single round of microplate-based protein misfolding cyclic amplification

Mbio
|January 2, 2014
PubMed

Insights

This study enhances protein misfolding cyclic amplification (PMCA) for faster, more robust prion detection in biological samples. The improved method allows for high-throughput prion detection, aiding in diagnostics and reducing disease transmission risks.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Cell-free assays are increasingly vital for prion detection in biological tissues and fluids.
  • Protein misfolding cyclic amplification (PMCA) is a sensitive prion detection tool but lacks robustness and speed for high-throughput applications.

Purpose of the Study:

  • To enhance the protein misfolding cyclic amplification (PMCA) method for increased robustness, rapidity, and high-throughput prion detection.
  • To develop a microplate-based PMCA assay capable of amplifying prions within a 48-hour period.

Main Methods:

  • Implemented improvements to the PMCA technique to maximize scrapie prion amplification in a single 48-hour round.
  • Utilized a microplate format for enhanced PMCA efficiency and suitability for high-throughput screening.
  • Validated the amplification rates and infectious titer of PMCA-generated prions against in vivo bioassays.

Main Results:

  • Achieved maximum prion amplification in a single 48-hour round using the enhanced PMCA technique.
  • Demonstrated that PMCA-formed prions exhibit amplification rates and infectious titers comparable to in vivo bioassays.
  • Successfully amplified prions from various species, including those causing human variant Creutzfeldt-Jakob disease.

Conclusions:

  • The enhanced PMCA technique offers a fast, reliable, and large-scale method for cell-free prion amplification from various species.
  • This improved assay approaches or matches the sensitivity and rapidity of other prion-seeded conversion assays.
  • The simplified, high-throughput assay can complement existing methods for urgent antemortem diagnostic tests, crucial for reducing transfusion risks and identifying asymptomatic carriers.